Adriënne Janssen is a seasoned Freelance Pharma Consultant with over two decades of experience in the pharmaceutical and biotechnology industries. Since April 2022, she has been offering her expertise through A3N LifeSciences Consult, undertaking pivotal roles such as:
- Project Manager and Technical Expert at Eurocept International BV (October 2023 - present), leading multiple technology transfer projects.
- Technology Transfer Expert at Batavia Biosciences (April - December 2023), specializing in the seamless transition of technologies within GMP environments.
- Interim QC Supervisor at HAL Allergy (December 2022 - July 2023), overseeing quality control processes and ensuring compliance.
- Training and Onboarding Support at PCS Pharmaceutical Consultancy Services (November 2022 - February 2023), facilitating the smooth integration of new team members.
- Project Manager TT at ProPharma Group (August 2022 - March 2023), managing technology transfer projects with a focus on regulatory compliance.
- Project Manager at SentryX B.V. (April - October 2022), steering projects to successful completion.
Before her freelance career, Adriënne served as the Manager of Technology Transfer at HAL Allergy Group from August 2018 to March 2022. In this role, she led a team of project managers, engineers, and technical writers responsible for introducing new products and processes from internal R&D and external CMO customers into GMP facilities.
Her previous positions include:
- Project/Program Manager at Bilthoven Biologicals (January 2017 - July 2018), where she was responsible for implementing the commercial production of polio vaccines, including process validation and regulatory submission, and involved in the implementation of WHO GAPIII standards.
- Project Manager at Genmab B.V. (July 2015 - December 2016), planning and monitoring research and early-stage development projects for therapeutic antibodies in cancer treatment.
- Contract Manufacturing Manager at Baxter International Inc. (February 2014 - June 2015), managing daily operations at Sanquin Amsterdam for blood plasma fractionation and leading a fractionation tech transfer project.
- Project Leader QC at TEVA Pharmachemie (February 2011 - January 2014), coordinating all QC activities related to product transfers, including analytical method transfer and stability testing.
- Task Team Leader (Project Leader) at Abbott Biologicals (formerly Solvay Biologicals) (September 2006 - February 2011), planning and coordinating the production of influenza vaccines for preclinical and clinical trials.
Adriënne began her career as a Research Technician at Utrecht University (2000 - 2006), working on projects involving ligand-targeted PEG-liposomes for anti-angiogenic therapy and molecular imprinting. She was involved in designing non-viral drug delivery systems and supervised ML-II laboratory operations.
With deep expertise in GMP regulations, technology transfer, project management, and quality control, Adriënne Janssen has consistently contributed to the success of the organizations she has been part of through her leadership and technical skills.
